Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 47/100

Termination Rate

14.3%

1 terminated out of 7 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

4 of 4 completed with results

Key Signals

4 with results80% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (5)
P 2 (1)

Trial Status

Completed4
Recruiting1
Enrolling By Invitation1
Terminated1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (7)

Research Network

Activity Timeline